Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma

BACKGROUND: New effective treatments for metastatic melanoma greatly improve survival in a proportion of patients. However biomarkers to identify patients that are more likely to benefit from a particular treatment are needed. We previously reported on a multimarker approach for the detection of het...

Descripción completa

Detalles Bibliográficos
Autores principales: Klinac, Dragana, Gray, Elin S, Freeman, James B, Reid, Anna, Bowyer, Samantha, Millward, Michael, Ziman, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060872/
https://www.ncbi.nlm.nih.gov/pubmed/24915896
http://dx.doi.org/10.1186/1471-2407-14-423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060872/
https://www.ncbi.nlm.nih.gov/pubmed/24915896
http://dx.doi.org/10.1186/1471-2407-14-423

Ejemplares similares